From: Serum GGT/ALT ratio predicts vascular invasion in HBV-related HCC
Risks | Univariate analysis | |
---|---|---|
OR (95% CI) | P | |
Age, n (%) | ||
  ≤ 60 | Reference |  |
  > 60 | 0.36 (0.15, 0.87) | 0.015 |
Sex, n (%) | ||
 Female | Reference |  |
 Male | 1.58 (0.6, 4.2) | 0.342 |
Albumin, n (%) | ||
  ≤ 40 | Reference |  |
  > 40 | 1.37 (0.74, 2.56) | 0.315 |
TB, n (%) | ||
  ≤ 20 | Reference |  |
  > 20 | 1.6 (0.5, 5.12) | 0.417 |
AFP, n (%) | ||
  ≤ 400 | Reference |  |
  > 400 | 2.11 (1.08, 4.12) | 0.029 |
Cirrhosis, n (%) | ||
 No | Reference |  |
 Yes | 0.93 (0.42, 2.08) | 0.864 |
Size, n (%) | ||
  ≤ 5 | Reference |  |
  > 5 | 2.68 (1.42, 5.07) | 0.002 |
Number, n (%) | ||
 Solitary | Reference |  |
 Multiple | 1.24 (0.6, 2.55) | 0.567 |
Tumor capsule, n (%) | ||
 Absence | Reference |  |
 Presence | 2.05 (1.09, 3.87) | 0.026 |
Differential, n (%) | ||
 Good | Reference |  |
 Moderate/poor | 4.71 (2.42, 9.17) |  < 0.001 |
BCLC, n (%) | ||
 A | Reference |  |
 B | 2.61 (1.32, 5.15) | 0.006 |
C | 2.88 (2.18, 3.42) |  < 0.001 |
ALBI Grade, n (%) | ||
 A | Reference |  |
 B | 1.27 (0.65, 2.46) | 0.485 |
GGT/ALT | ||
  ≤ 2.95 | Reference |  |
  > 2.95 | 1.86 (1.23, 3.33) | 0.037 |